Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
It activates the GLP-1 receptors in the gastrointestinal tract, pancreas, and brain to lower blood sugar levels in patients with type 2 diabetes and promote weight loss in obese and overweight individuals
They are no longer used as a first add-on in most NICE pathways but still have a role when cost or specific tolerability concerns make newer drugs unsuitable
bl, baseline
Wegovy might be a sensible first option if: You meet NICEs eligibility criteria and want a NICE-recommended option with several years of UK real-world data
US$ 27.51
US$ 29.19
US$ 27.43
US$ 28.83
US$ 25.07
US$ 27.80
US$ 22.76
US$ 20.40
US$ 23.26
